Status:
UNKNOWN
Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial
Lead Sponsor:
Onze Lieve Vrouw Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
This is prospective, randomized, multicenter, multinational, randomized (1:1) study. The aim of this study is to assess the importance of functional assessment of coronary artery disease prior to bypa...
Eligibility Criteria
Inclusion
- Patients with stable angina, unstable angina or NSTEMI candidate to CABG
- Significant LAD and/or LM lesion - proved by FFR or Angiography AND
- At least one more, angiographycally intermediate lesion
Exclusion
- Significant valvular disease with indication to surgical replacement
- Severe left ventricular dysfunction (EF\<35%)
- Acute STEMI
- Atrial fibrillation, if Maze procedure is planned
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT01810224
Start Date
March 1 2013
Last Update
March 13 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Center Aalst OLV Hospital
Aalst, Belgium, 9300
2
Department of Internal Medicine and Cardiology, University Hospital Brno
Brno, Czechia
3
Hungarian Institute of Cardiology
Budapest, Hungary